Work

First-in-human (FIH) trial evaluating immune activation and safety of PIN- 2 administered intravenously to patients with advanced solid tumors.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.2600

Authors: Colin Bier, Michael Millward, Dusan Kotasek, Kenneth J Gorelick, Joshua Brian Goldberg

Institution: The University of Adelaide

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947564243

Cites:

Cited by:

Related to: 10